The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Alkem Reports 17 Percentage Revenue and 22 Percentage EBITDA Growth in Q2 FY26
Mumbai, November 13, 2025: Alkem Laboratories Ltd., announced its standalone and consolidated financial results for the second quarter ended September…
MDI Gurgaon Achieves 100 Percent Placements for 2024–26 Batch; Highest Offer at INR 97.5 Lakh
Gurugram, April 23: Management Development Institute Gurgaon (MDI Gurgaon), one of India’s leading business institutions, announced wrapping up the final…
The Sandur Manganese & Iron Ores Limited (SMIORE) – Strategic business acquisition of Arjas Steel Private Limited
SMIORE has signed a Share Purchase Agreement (SPA) with an entity affiliated with ADV Partners, an Asia-focused private equity firm…